Separation of human liver microsomal tolbutamide hydroxylase and (S)- mephenytoin 4'-hydroxylase cytochrome P-450 enzymes

PK Srivastava, CH Yun, PH Beaune, C Ged and FP Guengerich

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-0146.

Purification and immunoinhibition studies have suggested that the hydroxylations of (S)-mephenytoin and tolbutamide are catalyzed by rather similar forms of human liver cytochrome P-450 (P-450). However, the two activities are not well correlated in vivo; sulfaphenzaole is a selective inhibitor of tolbutamide hydroxylation, and expression of P- 450 2C10 cDNA in yeast yields a protein that hydroxylates tolbutamide but not (S)-mephenytoin. The P-450 2C8, 2C9, and 2C10 cDNAs have all been isolated, and their sequences are known to be closely related (greater than 80%). Highly sensitive radiochromatographic assays were set up, and tolbutamide and (S)-mephenytoin hydroxylation activities were monitored during chromatography of human liver microsomal fractions. The two activities could be separated by chromatography, and proteins were purified to near-homogeneity that catalyzed either tolbutamide hydroxylation (P-450TB) or (S)-mephenytoin 4'-hydroxylation (P-450MP) but not both. Approximately 16 and 45% of the primary sequences of P-450TB and P-450MP, respectively, were determined by analysis of the tryptic peptides. The sequences of the P-450TB peptides matched those predicted by the P-450 2C9 and 2C10 cDNAs exactly; the P- 450MP peptides showed two mismatches (of 219 residues) with the P-450 2C10 sequence. Proteins with the P-450 2C10 and P-450 2C9 sequences were expressed in Saccharomyces cerevisiae grown under different nutritional conditions, and both were found to be proficient in the hydroxylation of tolbutamide but not (S)-mephenytoin. We conclude, on the basis of this and previous work, that 1) P-450s 2C8, 2C9, and 2C10 all catalyze the hydroxylation of tolbutamide and 2) the protein involved in polymorphic (S)-mephenytoin 4'-hydroxylation is closely related to but distinct from P-450 2C8, 2C9, and 2C10.

Volume 40, Issue 1, pp. 69-79, 07/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. Kohalmy, V. Tamasi, L. Kobori, E. Sarvary, J.-M. Pascussi, P. Porrogi, D. Rozman, R. A. Prough, U. A. Meyer, and K. Monostory Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane Receptor Drug Metab. Dispos., September 1, 2007; 35(9): 1495 - 1501. [Abstract] [Full Text] [PDF]

				S. Uchida, H. Yamada, X. D. Li, S. Maruyama, Y. Ohmori, T. Oki, H. Watanabe, K. Umegaki, K. Ohashi, and S. Yamada Effects of ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers. J. Clin. Pharmacol., November 1, 2006; 46(11): 1290 - 1298. [Abstract] [Full Text] [PDF]

				H. Echizen, M. Tanizaki, J. Tatsuno, K. Chiba, T. Berwick, M. Tani, F. J. Gonzalez, and T. Ishizaki Identification of CYP3A4 as the Enzyme Involved in the Mono-N-Dealkylation of Disopyramide Enantiomers in Humans Drug Metab. Dispos., August 1, 2000; 28(8): 937 - 944. [Abstract] [Full Text]

				K. Komatsu, K. Ito, Y. Nakajima, S.-i. Kanamitsu, S. Imaoka, Y. Funae, C. E. Green, C. A. Tyson, N. Shimada, and Y. Sugiyama Prediction of in Vivo Drug-Drug Interactions between Tolbutamide and Various Sulfonamides in Humans Based on in Vitro Experiments Drug Metab. Dispos., April 1, 2000; 28(4): 475 - 481. [Abstract] [Full Text]

				M. R. Wester, J. M. Lasker, E. F. Johnson, and J. L. Raucy CYP2C19 Participates in Tolbutamide Hydroxylation by Human Liver Microsomes Drug Metab. Dispos., March 1, 2000; 28(3): 354 - 359. [Abstract] [Full Text] [PDF]

				T. L. Nielsen, B. B. Rasmussen, J.-P. Flinois, P. Beaune, and K. Brøsen In Vitro Metabolism of Quinidine: The (3S)-3-Hydroxylation of Quinidine Is a Specific Marker Reaction for Cytochrome P-4503A4 Activity in Human Liver Microsomes J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 31 - 37. [Abstract] [Full Text]

				D. Hickman, J.-P. Wang, Y. Wang, and J. D. Unadkat Evaluation of the Selectivity of In Vitro Probes and Suitability of Organic Solvents for the Measurement of Human Cytochrome P450 Monooxygenase Activities Drug Metab. Dispos., March 1, 1998; 26(3): 207 - 215. [Abstract] [Full Text]

				G. N. Kumar, E. Dubberke, A. D. Rodrigues, E. Roberts, and J. F. Dennisen Identification of Cytochromes P450 Involved in the Human Liver Microsomal Metabolism of the Thromboxane A2 Inhibitor Seratrodast (ABT-001) Drug Metab. Dispos., January 1, 1997; 25(1): 110 - 115. [Abstract] [Full Text]